BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2159261)

  • 1. Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.
    Iwayama S; Ono N; Ohmura Y; Suzuki K; Aoki M; Nakazawa H; Oikawa M; Kato T; Okunishi M; Nishiyama Y; Yamanishi K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1666-70. PubMed ID: 9661001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.
    Griffiths A
    Drug Resist Updat; 2011 Dec; 14(6):251-9. PubMed ID: 21940196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.
    Wolfgang GH; Shibata R; Wang J; Ray AS; Wu S; Doerrfler E; Reiser H; Lee WA; Birkus G; Christensen ND; Andrei G; Snoeck R
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2777-84. PubMed ID: 19398642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current recommendations for the treatment of genital herpes.
    Leung DT; Sacks SL
    Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
    Seifer M; Hamatake RK; Colonno RJ; Standring DN
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3200-8. PubMed ID: 9835515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
    Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.
    Innaimo SF; Seifer M; Bisacchi GS; Standring DN; Zahler R; Colonno RJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1444-8. PubMed ID: 9210663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of carbocyclic oxetanocin G eyedrops in the treatment of herpes simplex corneal ulcers.
    Shiota H; Nitta K; Naito T; Mimura Y; Maruyama T
    Br J Ophthalmol; 1996 May; 80(5):413-5. PubMed ID: 8695561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review.
    Kulikowski T
    Pharm World Sci; 1994 Apr; 16(2):127-38. PubMed ID: 8032338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G; Snoeck R; Reymen D; Liesnard C; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):318-29. PubMed ID: 7649195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice.
    Braitman A; Swerdel MR; Olsen SJ; Tuomari AV; Lynch JS; Blue B; Michalik T; Field AK; Bonner DP; Clark JM
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1464-8. PubMed ID: 1656863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
    Yamanaka G; Tuomari AV; Hagen M; McGeever-Rubin B; Terry B; Haffey M; Bisacchi GS; Field AK
    Mol Pharmacol; 1991 Sep; 40(3):446-53. PubMed ID: 1896029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and selectivity of acyclovir.
    Elion GB
    Am J Med; 1982 Jul; 73(1A):7-13. PubMed ID: 6285736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.
    Pagano JS; Datta AK
    Am J Med; 1982 Jul; 73(1A):18-26. PubMed ID: 6285710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses.
    Field AK; Tuomari AV; McGeever-Rubin B; Terry BJ; Mazina KE; Haffey ML; Hagen ME; Clark JM; Braitman A; Slusarchyk WA
    Antiviral Res; 1990 Jan; 13(1):41-52. PubMed ID: 2159261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
    Terry BJ; Cianci CW; Hagen ME
    Mol Pharmacol; 1991 Oct; 40(4):591-6. PubMed ID: 1656194
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.